170 related articles for article (PubMed ID: 21447627)
1. The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation.
Sophocleous A; Landao-Bassonga E; Van't Hof RJ; Idris AI; Ralston SH
Endocrinology; 2011 Jun; 152(6):2141-9. PubMed ID: 21447627
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH
Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663
[TBL] [Abstract][Full Text] [Related]
3. Peripheral cannabinoid receptor, CB2, regulates bone mass.
Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
[TBL] [Abstract][Full Text] [Related]
4. Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.
Sophocleous A; Marino S; Logan JG; Mollat P; Ralston SH; Idris AI
J Biol Chem; 2015 Sep; 290(36):22049-60. PubMed ID: 26195631
[TBL] [Abstract][Full Text] [Related]
5. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
[TBL] [Abstract][Full Text] [Related]
6. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
[TBL] [Abstract][Full Text] [Related]
7. Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles.
Qiu S; Zhao F; Tang X; Pei F; Dong H; Zhu L; Guo K
Mol Cell Biochem; 2015 Jan; 399(1-2):131-41. PubMed ID: 25292314
[TBL] [Abstract][Full Text] [Related]
8. Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice.
Lai CF; Cheng SL; Mbalaviele G; Donsante C; Watkins M; Radice GL; Civitelli R
J Bone Miner Res; 2006 Dec; 21(12):1897-906. PubMed ID: 17002573
[TBL] [Abstract][Full Text] [Related]
9. CB(2) and TRPV(1) receptors oppositely modulate in vitro human osteoblast activity.
Rossi F; Bellini G; Tortora C; Bernardo ME; Luongo L; Conforti A; Starc N; Manzo I; Nobili B; Locatelli F; Maione S
Pharmacol Res; 2015 Sep; 99():194-201. PubMed ID: 26117426
[TBL] [Abstract][Full Text] [Related]
10. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
Xie H; Xie PL; Luo XH; Wu XP; Zhou HD; Tang SY; Liao EY
Osteoporos Int; 2012 Apr; 23(4):1425-36. PubMed ID: 21755404
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
Bab I; Zimmer A; Melamed E
Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
[TBL] [Abstract][Full Text] [Related]
13. Eucalyptol induces osteoblast differentiation through ERK phosphorylation in vitro and in vivo.
Lee DW; Kim KM; Park S; An SH; Lim YJ; Jang WG
J Mol Med (Berl); 2023 Sep; 101(9):1083-1095. PubMed ID: 37470800
[TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells.
Sun YX; Xu AH; Yang Y; Zhang JX; Yu AW
Biomed Res Int; 2015; 2015():874982. PubMed ID: 25685815
[TBL] [Abstract][Full Text] [Related]
15. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
Li J; Hao L; Wu J; Zhang J; Su J
Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
[TBL] [Abstract][Full Text] [Related]
16. The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice.
Rossi F; Bellini G; Torella M; Tortora C; Manzo I; Giordano C; Guida F; Luongo L; Papale F; Rosso F; Nobili B; Maione S
Br J Pharmacol; 2014 May; 171(10):2621-30. PubMed ID: 24308803
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting effect of microRNA-187-3p on osteogenic differentiation of osteoblast precursor cells by suppressing cannabinoid receptor type 2.
Xu A; Yang Y; Shao Y; Wu M; Sun Y
Differentiation; 2019; 109():9-15. PubMed ID: 31352121
[TBL] [Abstract][Full Text] [Related]
18. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
19. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.
Lin SJ; Ho HC; Lee YF; Liu NC; Liu S; Li G; Shyr CR; Chang C
Reprod Biol Endocrinol; 2012 Jun; 10():43. PubMed ID: 22676849
[TBL] [Abstract][Full Text] [Related]
20. CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.
Ofek O; Attar-Namdar M; Kram V; Dvir-Ginzberg M; Mechoulam R; Zimmer A; Frenkel B; Shohami E; Bab I
J Bone Miner Res; 2011 Feb; 26(2):308-16. PubMed ID: 20803555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
